Endeavor

Moffitt Trial Reports Higher Survival for HER2-Positive Breast Cancer Patients With Leptomeningeal Metastases

The phase 2 trial shows patients treated with radiation therapy followed by two antibodies delivered intrathecally had a median overall survival of 36 months

Personalized Melanoma Vaccine Shows 42% Reduction in Recurrence, Death Risk

New phase 3 findings build on earlier research and offer new hope for patients with high-risk melanoma following surgery

Can You Bust These Flu Myths?

From vaccine safety to flu complications, Moffitt infectious disease expert clears up common misconceptions about the flu

Infections Linked to 2.3 Million New Cancer Cases Worldwide

Researchers say many of these cancers are preventable with treatment or vaccines

This Winter Gives Rise to ‘Super Flu’

The CDC has reported 15 million flu cases this season, many caused by a new variant

Should I Get a Flu Shot?

Last year was considered the most severe since the 2017-18 flu season

Patient Meets Technologist Who Helped Develop Her Personalized Cancer Therapy

Tiffany Archibong credits the treatment for saving her life

What Should You Know About Measles?

There have been more than 200 cases across the U.S., including Florida

Are Personalized Vaccines the Future of Triple-Negative Breast Cancer Treatment?

Moffitt studies the use of dendritic cell vaccines to harness the immune system